Rxivist logo

De novo macrocyclic peptides for inhibiting, stabilising and probing the function of the Retromer endosomal trafficking complex

By Kai-En Chen, Qian Guo, Timothy A Hill, Yi Cui, Amy K Kendall, Zhe Yang, Ryan J Hall, Michael Healy, Joanna Sacharz, Suzanne J Norwood, Sachini Fonseka, Boyang Xie, Robert C Reid, Natalya Leneva, Robert G Parton, Rajesh Ghai, David Arthur Stroud, David P. Fairlie, Hiroaki Suga, Lauren Parker Jackson, Rohan D Teasdale, Toby Passioura, Brett M Collins

Posted 04 Dec 2020
bioRxiv DOI: 10.1101/2020.12.03.410779

The Retromer complex (Vps35-Vps26-Vps29) is essential for endosomal membrane trafficking and signalling. Mutations in Retromer cause late-onset Parkinsons disease, while viral and bacterial pathogens can hijack the complex during cellular infection. To modulate and probe its function we have created a novel series of macrocyclic peptides that bind Retromer with high affinity and specificity. Crystal structures show the majority of cyclic peptides bind to Vps29 via a Pro-Leu-containing sequence, structurally mimicking known interactors such as TBC1D5, and blocking their interaction with Retromer in vitro and in cells. By contrast, macrocyclic peptide RT-L4 binds Retromer at the Vps35-Vps26 interface and is a more effective molecular chaperone than reported small molecules, suggesting a new therapeutic avenue for targeting Retromer. Finally, tagged peptides can be used to probe the cellular localisation of Retromer and its functional interactions in cells, providing novel tools for studying Retromer function.

Download data

  • Downloaded 587 times
  • Download rankings, all-time:
    • Site-wide: 50,494
    • In biochemistry: 1,307
  • Year to date:
    • Site-wide: 12,167
  • Since beginning of last month:
    • Site-wide: 9,389

Altmetric data

Downloads over time

Distribution of downloads per paper, site-wide